Previous Article | Next Article ![]()
Journal of Virology, February 2001, p. 1643-1655, Vol. 75, No. 4
Ludwig Institute for Cancer Research,
Stockholm Branch, Karolinska Institute, S-17177 Stockholm, Sweden
Received 16 August 2000/Accepted 7 November 2000
We describe here the development of a reverse genetics system for
the phlebovirus Uukuniemi virus, a member of the
Bunyaviridae family, by using RNA polymerase I (pol
I)-mediated transcription. Complementary DNAs containing the coding
sequence for either chloramphenicol acetyltransferase (CAT) or green
fluorescent protein (GFP) (both in antisense orientation) were flanked
by the 5'- and 3'-terminal untranslated regions of the Uukuniemi virus
sense or complementary RNA derived from the medium-sized (M) RNA
segment. This chimeric cDNA (pol I expression cassette) was cloned
between the murine pol I promoter and terminator and the plasmid
transfected into BHK-21 cells. When such cells were either
superinfected with Uukuniemi virus or cotransfected with expression
plasmids encoding the L (RNA polymerase), N (nucleoprotein), and
NSs (nonstructural protein) viral proteins, strong CAT
activity or GFP expression was observed. CAT activity was
consistently stronger in cells expressing L plus N than following
superinfection. No activity was seen without superinfection, nor was
activity detected when either the L or N expression plasmid was
omitted. Omitting NSs expression had no effect on CAT activity or GFP
expression, indicating that this protein is not needed for viral RNA
replication or transcription. CAT activity could be serially passaged
to fresh cultures by transferring medium from CAT-expressing cells,
indicating that recombinant virus containing the reporter construct had
been produced. In summary, we demonstrate that the RNA pol I system,
originally developed for influenza virus, which replicates in the
nucleus, has strong potential for the development of an efficient
reverse genetics system also for Bunyaviridae members,
which replicate in the cytoplasm.
The procedures developed during the
1990s to genetically manipulate the genomes of negative-strand viruses
and to rescue infectious viruses entirely from cloned cDNAs, commonly
referred to as reverse genetics, have revolutionized the analyses of
viral gene expression and the dissection of cis-acting
regulatory sequences important for replication and transcription. They
have also paved the road for engineering these viruses for vaccine and
gene therapy purposes (6, 36). The ability to rescue
infectious viruses from cloned cDNAs has by now been well established
for nonsegmented, negative-strand viruses (Mononegavirales),
such as members of the Rhabdoviridae (22, 41,
48) and Paramyxoviridae (1, 5, 18, 19, 35) families. The development of similar protocols for
manipulating the genomes and creating viruses from cloned cDNAs of
segmented, negative-strand viruses, i.e., members of the
Orthomyxoviridae, Bunyaviridae, and
Arenaviridae families, have turned out to be much more
difficult. Although the ability to manipulate RNA segments of
influenza A viruses was developed more than a decade ago (10, 25), it was not until last year that the first reports on the rescue of infectious influenza A virus entirely from cloned cDNAs were
published (15, 20, 31, 32).
Members of the Bunyaviridae family, which comprises more
than 300 viruses (28) grouped into the five genera
Bunyavirus, Hantavirus, Nairovirus,
Phlebovirus, and Tospovirus, are enveloped viruses with a tripartite, single-stranded RNA genome of negative polarity. The L segment encodes the RNA-dependent RNA polymerase (L),
the M segment encodes the two spike proteins (G1 and G2) and in some
viruses a nonstructural protein (NSm), while the S segment
encodes the nucleoprotein (N) and in some viruses a nonstructural protein (NSs) (8, 40). Initiation of transcription of the viral mRNAs is primed by short sequences derived from the 5' end of
host mRNAs (2, 40, 43). This cap-snatching
mechanism is reminiscent of that first described for influenza virus
(21), with the important difference that cap snatching
occurs in the cytoplasm of Bunyaviridae-infected cells, as
opposed to the nucleus in influenza virus-infected cells. This is due
to the fact that Bunyaviridae members replicate exclusively
in the cytoplasm. As is the case for all negative-strand RNA viruses,
the templates for L polymerase-catalyzed replication and transcription
of Bunyaviridae members are the ribonucleoproteins (RNPs)
consisting of the full-length positive- or negative-strand RNA segments
associated with the N protein.
To date, methods to study the role of cis-acting sequences
at the 5' and 3' termini of viral RNA (vRNA) segments have been developed for Bunyamwera (BUN) virus (Bunyavirus)
(7) and Rift Valley fever (RVF) virus
(Phlebovirus) (24, 34), using the now
classical T7-vaccinia virus (T7-VV) system (16) to express a chloramphenicol acetyltransferase (CAT) reporter cDNA flanked by
5' and 3' vRNA ends. An important step was taken when Bridgen and
Elliott in 1996 (4) were able to rescue infectious BUN virus entirely from cloned cDNAs, although the procedure was
cumbersome and the efficiency of generating infectious virus was rather low.
To look for an alternative approach for developing a reverse genetics
system for Bunyaviridae, we have turned to the RNA
polymerase I (pol I) expression system, which was recently successfully
used to rescue infectious influenza virus (15, 31, 32).
This system, originally developed by Hobom and coworkers (30,
49), has been used to study cis-acting sequences
important for transcription and replication (14) and to
develop a procedure for indirect selection of recombinant influenza
viruses (12). An ambisense strategy to further simplify
the procedure was recently reported (20). In the pol I
system, cDNAs coding for viral RNA segments, or reporter genes
flanked by viral sequences, are cloned between the RNA pol I promoter
and terminator to generate transcripts that have correct 5' and 3' ends
without modifications such as a cap structure and a poly(A) tail
(12, 49). In the case of influenza virus, these pol I
transcripts are then replicated and transcribed in the nucleus by the
necessary viral proteins. Following transport of the RNPs to the
cytoplasm, infectious particles are assembled by budding at the plasma membrane.
We have adopted the pol I system to express reporter genes flanked by
the 5' and 3' noncoding sequences of the M RNA segment of Uukuniemi
(UUK) virus, a member of the Phlebovirus genus
(28). We have previously characterized
extensively the molecular and cell biology of UUK virus.
Full-length cDNAs corresponding to the L (6,423 nucleotides [nt])
(9), M (3,229 nt) (38), and S (1,720 nt)
(42) segments have been constructed, and cDNAs encoding the open reading frames (ORFs) for the L, G1, G2, N, and NSs
proteins have been derived (9, 26, 37, 44). As the first
step toward the generation of infectious virus from cloned cDNAs,
we show here that the pol I system can be used to synthesize chimeric
RNA templates, which, despite lacking a cap structure and poly(A) tail,
are transported to the cytoplasm, where they are amplified and
transcribed by the UUK virus replicase components supplied either by
superinfection with UUK virus or by expression of viral proteins from
separate plasmids. The L and N proteins were found to be necessary and
sufficient for transcription and replication, while NSs was completely
dispensable. We also show that CAT activity could be transferred
serially from culture to culture by passaging supernatants from
transfected and superinfected cells. This indicates that the chimeric
reporter RNA could be packaged into virus particles. Thus, the pol I
system holds great potential as an effective alternative approach for a
versatile reverse genetics system for members of the
Bunyaviridae family.
Cells and Virus.
BHK-21 cells (American Type Culture
Collection) were grown on plastic dishes in Eagle's minimal essential
medium (EMEM) supplemented with 10% fetal calf serum (FCS; Life
Technologies, Gibco-BRL), 5% tryptose phosphate broth, 2 mM
L-glutamine, 100 IU of penicillin/ml, and 100 µg of
streptomycin/ml. The origin and the preparation of stock virus from the
prototype strain S23 of UUK virus have been described elsewhere
(33). The stock virus had a titer of 2 × 108 PFU/ml. Cells were infected with a multiplicity of
infection (MOI) of about 5 to 10 PFU/cell.
Construction of plasmids.
The PCR primers used for plasmid
constructions are shown in Table 1.
Plasmids designed for expression of UUK virus RNA molecules by RNA pol
I in vivo carried the rRNA gene (rDNA) promoter region (
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.4.1643-1655.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Reverse Genetics System for Uukuniemi Virus
(Bunyaviridae): RNA Polymerase I-Catalyzed Expression of
Chimeric Viral RNAs
and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
251 to
1 relative to the 45S pre-rRNA start point) and the rDNA
terminator sequence (+571 to +745 relative to the 3' end of the 28S
rDNA) derived from murine rDNA (49). Between these two
elements, UUK virus cDNA constructs from the M segment were exactly
inserted in antisense orientation for vRNA expression (primer RF2/RF9)
or in sense orientation for viral complementary (cRNA) expression
(primer RF33/RF34). For efficient detection of protein expression
following transcription and replication, the G1/G2 (p110) ORF in
plasmid pRF7, encoding the full-length UUK virus M RNA (UUK M vRNA)
segment, was replaced by reporter genes encoding CAT or a modified
(enhanced) green fluorescent protein (GFP) (R. Flick and G. Hobom,
unpublished data), using two PCR fragments (primers RF4B/RF10 and
RF5/RF6, respectively) (Fig. 1; Table 1),
without changing any of the nucleotides in the 5' and 3' untranslated
regions (UTRs) of the UUK M segment. This resulted in pRF33
(UUK-M-CAT-vRNA), pRF31 (UUK-M-GFP-vRNA), or pRF19 (UUK-M-CAT-cRNA),
respectively.
TABLE 1.
Oligonucleotide primers used to construct plasmids

View larger version (22K):
[in a new window]
FIG. 1.
Schematic diagram of the cloning strategy for
constructing chimeric UUK virus reporter plasmids. Two PCR fragments,
one containing the murine pol I promoter and the UUK M vRNA 5' UTR
(RF10/4B) and the other containing the CAT (RF5/6) or GFP (RF7B/8) ORF,
were ligated with the large ApaI-NcoI fragment
from plasmid pRF7 containing the UUK M vRNA 3' UTR and the pol I
terminator. This gave plasmids pRF33 (UUK M-CAT) and pRF31 (UUK M-GFP).
Plasmid pRF20 was constructed by inserting multiple cloning sites
immediately downstream of the UUK M vRNA 5' UTR, using the two PCR
fragments RF10/30 and RF5/6, respectively (see also Materials and
Methods).
|
Transfection and superinfection with UUK virus. Plasmid DNA was transfected into subconfluent BHK-21 cells (3 × 106 to 6 × 106) using 2 to 4 µg of the respective plasmid and 8 to 20 µl of liposome plus buffer (LipofectAMINE PLUS; Life Technologies, Gibco-BRL) mixed in serum-free EMEM and incubated for 15 min at room temperature. After addition of 12 to 30 µl of liposome reagent, incubation was continued for a further 15 min. The cells were incubated at 37°C with the DNA-Lipofectamine mixture for 3 to 5 h. To determine the efficiency of transfection, plasmid pHL2823, expressing enhanced GFP (EGFP) under the cytomegalovirus (CMV) promoter (Flick and Hobom, unpublished), was transfected similarly. After further incubation for 20 h in EMEM containing 10% FCS and 5% tryptose phosphate broth, the transfected cells were washed with adsorption medium (EMEM supplemented with 20 mM HEPES and 0.2% bovine serum albumin) and superinfected with UUK virus at an MOI of 5 to 10 PFU/cell. After a 60-min adsorption period, the cells were washed once and incubated with adsorption medium for 15 to 30 h. A complete replication cycle takes place during this period.
CAT assay. Cell extracts were prepared as described by Gorman et al. (17). In an initial series, 50 µl of each cell lysate (prepared from 106 cells in the case of cotransfection experiments or from 3 × 106 cells in the case of superinfection experiments), and depending on the results, serially diluted samples of the various cell lysates were mixed with 10 µl of acetyl coenzyme A (4 mM) and 10 µl of fluorescence-labeled chloramphenicol (boron dipyrromethane difluoride fluorophore substrate; Flash Cat kit; Stratagene) and incubated at 37°C for 2 h. For extraction of reaction products, 0.5 ml of ethylacetate was added; after centrifugation for 1 min at 15,000 × g, the upper phase containing the reaction products was isolated and the solvent was evaporated. The resulting pellet was resuspended in 20 µl of ethylacetate, and the reaction products were separated by thin-layer chromatography (TLC plates, 20 by 20 cm; Silica Gel 60; Merck) using a solvent mixture (mobile phase) of chloroform and methanol (87:13). Finally, the reaction products were visualized by UV illumination, documented by photography, and evaluated using WinCam software (Cybertech, Berlin, Germany) or Quantity One (Bio-Rad). Ratios of activities were calculated based on at least three independent sets of serial dilutions of cell lysates down to a level of 30 to 50% product formation.
Indirect immunofluorescence microscopy. BHK-21 cells grown on coverslips were transiently transfected as described above. Five to eight hours after transfection, the cells were washed with phosphate-buffered saline (PBS), fixed with 3% paraformaldehyde in PBS for 15 min at room temperature, washed with PBS again, quenched with 10 mM glycine for 20 min at room temperature, and finally washed with PBS. Depending on the antibodies used, the cells were permeabilized either with 0.1% Triton X-100 for 30 min or with methanol for 2 min at room temperature. Cells were incubated with PBS containing 0.1% bovine serum albumin and incubated for 30 min with a monoclonal antibody against the N protein (J. Veijola, A. Bergström, and R. F. Pettersson, unpublished data) and a rabbit polyclonal antiserum against NSs (44). Primary antibodies were visualized with tetramethyl rhodamine isothiocyanate-conjugated anti-mouse immunoglobulin G or fluorescein isothiocyanate-conjugated anti-rabbit immunoglobulin G secondary antibody, washed, and mounted in 50% glycerol containing 50 mM Tris-HCl (pH 8.0) and 9.2 mM p-phenylenediamine.
To visualize GFP expression, coverslips were immersed in PBS instead of the standard mounting solution, and fluorescence was monitored at 48 h after transfection with expression plasmids pHL2823 (CMV-GFP) and pRF31 (UUK M-GFP). Immunofluorescence micrographs were obtained either with an Axiophot (Zeiss) or an Eclipse E1000M (Nikon) fluorescence microscope. The latter was equipped with a Spot charge-coupled device camera (Diagnostic Instruments, Inc.).Serial passaging of virus-containing supernatants. BHK-21 cells were cotransfected with plasmid pRF33 (UUK M-CAT vRNA), together with the L (pCMV-UUK-L) and N (pCMV-UUK-N) expression plasmids, followed by superinfection with UUK virus at an MOI of 5 to 10 PFU/cell 20 h later. Cells were analyzed for CAT activity 30 h postinfection, and the corresponding supernatants were used for virus passaging. Cell debris was removed by centrifugation at 10,000 rpm (13,000 × g) for 5 min; a 2-ml sample of undiluted supernatant was used to infect a dish containing 6 × 106 BHK-21 cells and incubated for 60 min. After a change of medium (EMEM, 10% FCS) and incubation for 24 to 30 h, cells and supernatants were treated and passaged another round as described above.
| |
RESULTS |
|---|
|
|
|---|
General strategy of the pol I-driven expression system. Our strategy to develop a reverse genetics system for UUK virus by using the RNA pol I expression system basically followed the one established for influenza virus (12, 13, 14, 30, 31, 32, 49). Reporter cDNAs containing the exact ORF for either CAT or GFP (in antisense orientation) were flanked either by the 5' (185-nt) and 3' (17-nt) ends of the M vRNA segment or by the cRNA ends (17 and 185 residues, respectively; only for CAT) (Fig. 1 and 2) (38). The CAT and GFP ORFs exactly replaced that of p110, the precursor of G1 and G2 (38, 46), such that no extra nucleotides or any other changes were introduced in the 5' or 3' UTR. These chimeric cDNAs were then cloned into plasmid pRF42 (Fig. 2) or pHL1261 (12) between the promoter and terminator of the murine rDNA gene to generate plasmids pRF33 (expressing CAT-M vRNA), pRF31 (GFP-M vRNA) (Fig. 1), and pRF19 (CAT-M cRNA).
In initial control experiments using the pol I CAT-M vRNA construct, we observed a weak CAT activity in the absence of any viral proteins provided from expression plasmids or superinfection. Analysis of the nucleotide sequence upstream of the CAT ORF (i.e., within and beyond of the pol I terminator [Fig. 1]) revealed an AUG codon in frame with the CAT initiator AUG with no intervening in-frame stop codon. We assumed that a weak cryptic promoter upstream of the AUG was generating a transcript that could be translated into an active CAT enzyme. We therefore introduced an oligonucleotide encoding translational stop codons in all three ORFs in the NheI site (Fig. 1; Table 1) between the two AUGs. This completely abolished the background CAT activity. This modification was introduced in the three plasmids pRF19, pRF31, and pRF33. Based on the results from the influenza system, pol I-driven transcription of the reporter RNAs will initiate and terminate exactly at the 5' and 3' of the inserted cDNAs, thus giving rise to transcripts with the correct vRNA or cRNA ends (12, 49). The nucleotide sequences and the strategy for the synthesis of the vRNA sense transcript are shown in Fig. 1 and 2. Following transport to the cytoplasm, these pol I transcripts would be transcribed and replicated by the necessary viral proteins either expressed from plasmids encoding the individual proteins or provided by superinfection with UUK virus. For the synthesis of viral proteins, plasmids expressing mRNAs for L (pCMV-UUK-L), N (pCMV-UUK-N), or NSs (pCMV-UUK-NSs) under the CMV promoter were constructed from previously cloned cDNAs containing the corresponding ORFs. Immunofluorescence analyses of transfected cells showed that N and NSs were efficiently synthesized (data not shown).Expression of CAT and GFP from chimeric cDNAs flanked by the
UUK M vRNA or cRNA 5' and 3' ends.
The reporter plasmid pRF33
(CAT-M vRNA) or pRF19 (CAT-M cRNA) was introduced into BHK-21 cells by
liposome-mediated transfection. Control experiments using a CMV-EGFP
expression plasmid pHL2823 (Flick and Hobom, unpublished) indicated a
transfection efficiency of about 20 to 25% (see Fig. 4A). To drive
replication and transcription of the chimeric RNA, cells were either
infected with UUK virus 20 to 24 h after transfection or
cotransfected with expression plasmids encoding L, N, and NSs. Some
cultures were both cotransfected with the expression plasmids and
superinfected with virus. As shown in Fig.
3, CAT activity was readily detected in
lysates from cells transfected with pRF33 and superinfected with UUK
virus (lane 2). Interestingly, CAT activity was about 2.4-fold stronger in the lysate from pRF33-transfected cells expressing L, N, and NSs
from the plasmids (lane 3) than in that from superinfected cells
(activity arbitrarily set at 100%). Superinfection combined with the
expression plasmids did not further enhance CAT activity (lane 4).
|
|
Optimization of reporter gene expression.
To find the optimal
conditions for reporter expression, cells were transfected with
different ratios of the L, N, and NSs expression plasmids. As shown in
Fig. 5A, the NSs
protein was found to be completely dispensable for CAT expression,
since the same level of activity was observed without NSs and in the
presence of increasing amounts of NSs plasmids. The importance of the
relative levels of L and N expression was also analyzed. No activity
was observed in the absence of the L (Fig. 5B, control lane) or N (Fig.
5C, control lane) plasmid. As shown in Fig. 5B and C, the molar ratio
between the L and N expression plasmids was not critical. Molar N:L
plasmid ratios of 8:1 (Fig. 5B) or molar L:N plasmid ratio of 8:1 (Fig.
5C) yielded similar levels of CAT activity. Since NSs was not required
for CAT expression, plasmid pCMV-UUK-NSs was omitted from the
expression studies described below.
|
|
|
Effect of CTE sequences on CAT expression.
Pol I transcripts
lack a cap structure and a poly(A) tail. This is also true for the
chimeric reporter transcripts (12, 49). We initially
worried that these RNA species would be inefficiently exported from the
nucleus to the cytoplasm. To analyze if nuclear export could be further
enhanced, we first inserted additional restriction enzyme cleavage
sites (Table 1) into pRF33 (UUK M-CAT) exactly between the CAT
translation termination codon and the UUK M segment 5' UTR, generating
plasmid pRF20 (Fig. 1). We then inserted a longer (MPMV 566) and a
shorter (MPMV 250) version of the CTE sequence from MPMV into pRF20
(Fig. 8). This CTE sequence has been
shown to greatly enhance export of the intron-containing MPMV RNA from
the nucleus (3, 11). The CTE sequences were inserted in
either the sense or the antisense orientation (Fig. 8A). The pol I
expression cassette and the L and N expression plasmids were
cotransfected into BHK-21 cells, and cell lysates were analyzed for CAT
activity 24 h later. As seen in Fig. 8B, the CTE sequence in
either orientation had no enhancing effect on the reporter gene
activity (lanes 4 to 7). The CTE in the antisense orientation had a
slight inhibitory effect on CAT activity (lanes 6 and 7), possibly
because the stem-loop structure in this orientation constitutes a
relative physical barrier for the RNA polymerase; alternatively, the
sequence context in the antisense orientation could interfere with
replication or transcription signals in the noncoding region of the UUK
virus segment. The results also showed that the additional restriction
enzyme cleavage sites introduced into pRF20 had no disturbing effect on
CAT expression compared to pRF33 (lanes 2 and 3).
|
Generation of recombinant UUK virus.
Finally, we analyzed
whether the chimeric reporter RNA could be packaged into infectious
virus particles that could be serially passaged to fresh cultures.
BHK-21 cells were either cotransfected with the reporter plasmid pRF33
(CAT-M vRNA) and the L and N expression plasmids or transfected with
the reporter plasmid alone, followed in both cases by superinfection
with UUK virus 20 h later. The medium was collected 30 h
later (i.e., 50 h posttransfection) and used to infect new BHK-21
cultures. This was repeated for another cycle. From each passage, cell
lysates were analyzed for CAT activity. As shown in Fig.
9, CAT activity was strong in cells transfected with the combination of the three plasmids and infected with UUK virus (lane 1). CAT activity could be passaged at least twice,
although the activity was reduced between each passage (lanes 1 to 3).
If superinfection was omitted, no CAT activity could be detected upon
passaging (data not shown), nor could CAT activity be passaged if cells
were transfected only with the reporter plasmid followed by
superinfection (lanes 4 to 6).
|
| |
DISCUSSION |
|---|
|
|
|---|
In this study, we have successfully adopted the RNA pol I transcription system (30, 31, 49) for the development of a reverse genetics protocol for members of the Bunyaviridae family. As a model virus, we used UUK virus, a member of the Phlebovirus genus. Reporter cDNAs encoding CAT or GFP flanked by the terminal sequences of the UUK M RNA segment were transcribed in the cell nucleus by pol I, transported to the cytoplasm, and transcribed and amplified by the RNA polymerase L in the presence of the nucleoprotein N provided either from expression plasmids or by superinfection with UUK virus. Our results indicate that expression of the L and N proteins alone yielded more efficient reporter expression than could be achieved by superinfection and that the nonstructural NSs protein was completely dispensable for CAT activity. Finally, CAT activity could be serially passaged from culture to culture, indicating that the chimeric reporter RNA was packaged into virions.
We decided to use the 5' and 3' untranslated sequences from the M RNA segment to flank the reporter ORFs, rather than those from the L or S segment. In virus-infected BHK-21 cells, the M RNA segment is synthesized in a twofold molar excess over the L RNA and a fourfold excess over the S RNA (33), suggesting that the M RNA may possess the strongest promoter. In addition, the S RNA is transcribed into two subsegmental mRNAs encoding N and NSs using an ambisense strategy (42), which might complicate the use of the terminal sequences from this RNA segment. Our previous results have indicated that the mRNA transcribed from the M segment and translated into p110, the G1/G2 precursor, is about 100 nt shorter than the M vRNA template (R. Rönnholm and R. Pettersson, unpublished data) due to an as yet uncharacterized transcriptional termination signal. To ensure proper transcription termination of the reporter mRNAs, we therefore included the whole 185-residue-long UTR from the 5' end of the vRNA (or 3' end of the cRNA, depending on the polarity of the construct). Previous work with BUN (7), and RVF (34) viruses has shown that the extreme 3' end contains sequence elements critical for transcription initiation.
The fact that pol I reporter transcripts are noncapped and nonpolyadenylated raised the concern that these RNAs would not be efficiently transported out of the nucleus. In the case of influenza virus, the pol I transcripts do not have to exit the nucleus, since transcription and replication of vRNAs take place in the nucleus. In contrast, Bunyaviridae members replicate solely in the cytoplasm and the pol I transcripts therefore have to be exported from the nucleus. Our results showed that these concerns were unfounded, since CAT and GFP activities were readily detected. Newly synthesized nuclear RNA species rapidly associate with a set of proteins to form RNP structures. Some of these proteins contain an export signal and serve as export factors that guide the RNPs to and through the nuclear pore complex (29). We can only speculate that such an export factor(s) binds to our chimeric reporter RNA and facilitates its export to the cytoplasm. The CTE of MPMV has been shown to stimulate the export of unspliced RNAs from the nucleus (3, 11). To analyze whether the CTE could further enhance the export of pol I transcripts as assayed by increased reporter activity, we introduced two CTE variants in the sense or antisense orientation downstream of the 5' UTR of the CAT-M vRNA. These constructs did not enhance CAT expression, suggesting either that the CTE does not work in this sequence context or that the RNA export is already high enough to allow amplification of the reporter RNA by the viral proteins.
The finding that expression of the L and N proteins was more efficient compared to superinfection in stimulating CAT activity is interesting. One can only speculate as to the reason for this result. For all negative-strand RNA viruses, the template for transcription and replication is an RNP made up of the vRNA and the nucleocapsid protein. The formation of such RNPs is thus a prerequisite for the polymerase to transcribe and replicate template RNAs. It is conceivable that in virus-infected cells, transcription, replication, and viral protein synthesis are compartmentalized in some kind of "virus factories" to which the pol I transcripts might not readily have access. Thus, the pol I transcripts would have a rather low probability of being encapsidated by the N protein. In contrast, newly synthesized virion-derived RNAs would immediately associate with newly synthesized N protein and thus serve as templates for further replication and transcription. In L- and N-expressing cells, such competition and spatial constraints would not exist, resulting in efficient transcription and replication of the pol I transcripts. In addition, it is also likely that rather few pol I transcripts reach the cytoplasm and that they are simply outcompeted by the much more efficient vRNA synthesis.
In the experiments described here, we used the murine pol I promoter/terminator sequences to express the reporter constructs in BHK-21 cells. Although a transfection rate of 20 to 25% was regularly achieved, the use of the human pol I promoter and highly transfectable human embryonic kidney cells (293T) (20, 31, 32) has the potential to further increase the efficiency of reporter expression.
The function of the S RNA segment-derived NSs protein has remained elusive. We found that NSs was not required for CAT activity. Previous work with a natural mutant of RVF virus (clone 13), which has a large internal in-frame deletion in the NSs gene, has shown that it replicates normally in some cell lines while establishing abortive infections in others, and that it is avirulent in mice and hamsters (27, 47). Using an in vitro transcription-replication system, it was recently shown that NSs of RVF virus had neither a stimulatory nor an inhibitory effect on transcription (24, 34). Finally, NSs has similarly been shown not to be required for the transcription of BUN virus RNAs (7). Recently, an NSs deletion mutant of BUN virus was made by using a reverse genetics system (A. Bridgen, J. K. Fazakerley, and R. M. Elliott, Abstr. XIth Int. Congr. Virol., abstr. VW47.06, 1999). This mutant grew to somewhat lower titers than wild-type virus, had a small-plaque phenotype, displayed a reduced shutoff of host cell protein synthesis, and had an attenuated pathogenicity when inoculated into mice. Our results reported here are thus in conformity with these results showing that NSs is not essential for transcription or replication in tissue culture cells.
One important question in regard to our results is whether the pol I transcript is amplified by replication. Although we have not directly quantified RNA synthesis, we argue that the observed high expression level of CAT and GFP could not have been achieved unless replication had occurred. Immunofluorescence analysis showed that individual cells displayed a very strong GFP signal. Based on our previous experience (13, 14), the overall level of CAT activity was much higher than that obtained in the influenza virus pol I system, even compared to the most effective influenza virus up-regulation mutant. Finally, the fact that extracellular medium from transfected and UUK virus-superinfected cells could be used to serially passage CAT activity strongly suggests that the pol I transcript must have been amplified and packaged.
A reverse genetics system was developed some years ago for BUN virus
(4, 7). Using the T7-VV RNA polymerase-driven system, full-length L, M, and S antigenome RNA segments were expressed from
plasmids under the T7 RNA polymerase promoter. Correct 3' ends were
generated with the hepatitis
ribozyme. All viral proteins were
expressed under the T7 promoter from plasmids encoding L, G1, G2, NSm,
N, and NSs. This is to date the only system that has allowed the rescue
of an infectious Bunyaviridae member entirely from cloned
cDNAs without the use of the homologous helper virus. Although constituting a major advance in Bunyaviridae
research, this system still suffers from low efficiency and the
need to use the VV helper to drive expression.
A reverse genetics system has also been developed for RVF virus, which like UUK virus is a phlebovirus (24, 34). In this system, the antisense CAT reporter cDNA was expressed using the T7-VV system, while the L and N proteins were supplied from VV recombinants. No recombinant RVF virus has been reported to have been produced using this system.
Arenaviruses also contain a segmented (bipartite), negative-strand genome (39). Recently, the first report on the development of a reverse genetics system for lymphocytic choriomeningitis virus was published (23). Although no recombinant virus was rescued, it was shown that only the RNA polymerase (L) and nucleoprotein (NP) proteins were sufficient to support transcription and replication of a CAT reporter flanked by 5'- and 3'-terminal viral sequences. Both the reporter transcript and the viral proteins were expressed by using the T7-VV system.
The pol I system offers clear advantages over the VV-based reverse genetics systems used for many other negative-strand viruses. VV has been used either to direct the synthesis of the T7 RNA polymerase (16), which then drives the expression of the reporter construct and the viral proteins (1, 5, 18, 19, 22, 23, 41, 48), or to express the viral helper proteins directly (7, 24, 34). VV introduces into the cell a number of unwanted enzymatic activities, which are avoided by using the pol I system. In addition, there is no need to remove the VV, by physical or biochemical means (22, 41, 48), by passaging the virus through cells not permissive to VV (4) or by using a variant VV (MVA-T7) which does not replicate in mammalian cells (45). The pol I system also has the advantage of generating the exact 5' and 3' ends of the RNA transcripts, thus avoiding the need for expressing runoff transcripts from restriction enzyme-cleaved plasmids or the use of a ribozyme to produce the correct 3' end.
The pol I system has recently been successfully developed to reconstitute infectious influenza virus entirely from cloned cDNAs (15, 20, 31, 32). Our present results suggest that this could also be possible for Bunyaviridae members. In analogy to the influenza virus protocol, all three full-length RNA segments would be expressed from the pol I promoter, preferably as antigenomes (positive strands) (4, 22, 41), while the L, G1, G2, N, and possibly also the NSs proteins would be expressed from plasmids using the CMV promoter. Such a system would allow further characterization of cis- and trans-acting determinants important for the regulation of transcription and replication, as well as for virus maturation and packaging. It might also allow for the generation of genetically altered recombinant viruses to study structure-function relationships and molecular aspects of viral pathogenicity and the engineering of effective attenuated vaccines. It also remains to be investigated whether this approach is generally applicable to Bunyaviridae members other than UUK virus, such as the medically important hanta- and nairoviruses.
| |
ACKNOWLEDGMENTS |
|---|
We thank Anita Bergström and Elisabeth Raschperger for excellent technical assistance. We are grateful to Gerd Hobom for the pol I plasmids, Marie-Louise Hammarskjöld for the MPMV CTE fragment, and Richard Elliott for providing the full-length UUK L cDNA.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Ludwig Institute for Cancer Research, Stockholm Branch, Karolinska Institute, Box 240, S-17177 Stockholm, Sweden. Phone: 468-310701. Fax: 468-332812. E-mail: rpet{at}licr.ki.se.
Present address: Centre for Microbiological Preparedness, Swedish
Institute for Infectious Disease Control, S-17182 Solna, Sweden.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Baron, M. D., and T. Barrett. 1997. Rescue of rinderpest virus from cloned cDNA. J. Virol. 71:1265-1271[Abstract]. |
| 2. |
Bishop, D. H. L.,
M. E. Gay, and Y. Matsuoko.
1983.
Nonviral heterogeneous sequences are present at the 5' ends of one species of snowshoe hare bunyavirus S complementary RNA.
Nucleic Acids Res.
11:6409-6418 |
| 3. |
Bray, M.,
S. Prasad,
J. W. Dubay,
E. Hunter,
K. T. Jeang,
D. Rekosh, and M.-L. Hammarskjöld.
1994.
A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type I expression and replication Rev-independent.
Proc. Natl. Acad. Sci. USA
91:1256-1260 |
| 4. |
Bridgen, A., and R. M. Elliott.
1996.
Rescue of a segmented negative-strand RNA virus entirely from cloned complementary DNAs.
Proc. Natl. Acad. Sci. USA
93:15400-15404 |
| 5. |
Collins, P. L.,
M. G. Hill,
E. Camargo,
H. Grosfeld,
R. M. Chanock, and B. R. Murphy.
1995.
Production of infectious respiratory syncytial virus from cloned cDNA confirms an essential role for the transcription elongation factor from the 5' proximal open reading frame of the M2 mRNA in gene expression and provides a capability for vaccine development.
Proc. Natl. Acad. Sci. USA
92:11563-11567 |
| 6. | Conzelmann, K.-K. 1998. Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes. Annu. Rev. Genet. 32:123-162[CrossRef][Medline]. |
| 7. | Dunn, E. F., D. C. Pritlove, H. Jin, and R. M. Elliott. 1995. Transcription of a recombinant Bunyavirus RNA template by transiently expressed Bunyavirus proteins. Virology 211:133-143[CrossRef][Medline]. |
| 8. | Elliott, R. M., C. S. Schmaljohn, and M. S. Collett. 1991. Bunyaviridae genome structure and gene expression. Curr. Top. Microbiol. Immunol. 169:91-141[Medline]. |
| 9. |
Elliott, R. M.,
E. Dunn,
J. F. Simons, and R. F. Pettersson.
1992.
Nucleotide sequence and coding strategy of the Uukuniemi virus L RNA.
J. Gen. Virol.
73:1745-1752 |
| 10. |
Enami, M.,
W. Luytjes,
M. Krystal, and P. Palese.
1990.
Introduction of site-specific mutations into the genome of influenza virus.
Proc. Natl. Acad. Sci. USA
87:3802-3805 |
| 11. | Ernst, R. K., M. Bray, D. Rekosh, and M.-L. Hammarskjöld. 1997. A structured retroviral RNA element that mediates nucleocytoplasmic export of intron-containing RNA. Mol. Cell. Biol. 17:135-144[Abstract]. |
| 12. | Flick, R., and G. Hobom. 1999. Transient bicistronic vRNA segments for indirect selection of recombinant influenza viruses. Virology 262:93-103[CrossRef][Medline]. |
| 13. |
Flick, R., and G. Hobom.
1999.
Interaction of influenza virus polymerase with viral RNA in the `corkscrew' conformation.
J. Gen. Virol.
80:2565-2572 |
| 14. | Flick, R., G. Neumann, E. Hofmann, E. Neumeier, and G. Hobom. 1996. Promoter elements in the influenza vRNA terminal structure. RNA 2:1046-1057[Abstract]. |
| 15. |
Fodor, E.,
L. Devenish,
O. G. Engelhardt,
P. Palese,
G. G. Brownlee, and A. Garcia-Sastre.
1999.
Rescue of influenza A virus from recombinant DNA.
J. Virol.
73:9679-9682 |
| 16. |
Fuerst, T. R.,
E. G. Niles,
F. W. Studier, and B. Moss.
1986.
Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.
Proc. Natl. Acad. Sci. USA
83:8122-8126 |
| 17. |
Gorman, C. M.,
L. F. Moffat, and B. H. Howard.
1982.
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Mol. Cell. Biol.
2:1044-1051 |
| 18. | He, B., R. G. Paterson, C. D. Ward, and R. A. Lamb. 1997. Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology 237:249-260[CrossRef][Medline]. |
| 19. | Hoffman, M. A., and A. K. Banerjee. 1997. An infectious clone of parainfluenza virus type 3. J. Virol. 71:4272-4277[Abstract]. |
| 20. | Hoffmann, E., G. Neumann, G. Hobom, R. G. Webster, and Y. Kawaoka. 2000. Ambisense approach for the generation of influenza A virus: vRNA and mRNA synthesis from one template. Virology 267:310-317[CrossRef][Medline]. |
| 21. | Krug, R. M., F. V. Alonso-Caplen, I. Julkunen, and M. G. Katze. 1989. Expression and replication of influenza virus genome, p. 89-152. In R. M. Krug (ed.), The influenza viruses. Plenum Press, New York, N.Y. |
| 22. |
Lawson, N. D.,
E. A. Stillman,
M. A. Whitt, and J. K. Rose.
1995.
Recombinant vesicular stomatitis viruses from DNA.
Proc. Natl. Acad. Sci. USA
92:4477-4481 |
| 23. |
Lee, K. J.,
I. S. Novella,
M. N. Teng,
M. B. A. Oldstone, and J. C. de la Torre.
2000.
NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs.
J. Virol.
74:3470-3477 |
| 24. | Lopez, N., R. Muller, C. Prehaud, and M. Bouloy. 1995. The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules. J. Virol. 69:3972-3979[Abstract]. |
| 25. | Luytjes, W., M. Krystal, M. Enami, J. D. Pavin, and P. Palese. 1989. Amplification, expression, and packaging of a foreign gene by influenza virus. Cell 59:1107-1113[CrossRef][Medline]. |
| 26. | Melin, L., R. Persson, A. Andersson, A. Bergström, R. Rönnholm, and R. F. Pettersson. 1995. The membrane glycoprotein G1 of Uukuniemi virus contains a signal for localization to the Golgi complex. Virus Res. 36:49-66[CrossRef][Medline]. |
| 27. | Muller, R., J.-F. Saluzzo, N. Lopez, T. Dreier, M. Turell, J. Smith, and M. Bouloy. 1995. Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am. J. Trop. Med. Hyg. 53:405-411. |
| 28. | Murphy, F. A., C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers. 1995. Virus taxonomy, 6th report of the International Committee of Taxonomy of Viruses. Arch. Virol. (Suppl. 10):300-315. |
| 29. | Nakielny, S., and G. Dreyfuss. 1999. Transport of proteins and RNAs in and out of the nucleus. Cell 99:677-690[CrossRef][Medline]. |
| 30. | Neumann, G., A. Zobel, and G. Hobom. 1994. RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology 202:477-479[CrossRef][Medline]. |
| 31. |
Neumann, G.,
T. Watanabe,
H. Ito,
S. Watanabe,
H. Goto,
P. Gao,
M. Hughes,
D. R. Perez,
R. Donis,
E. Hoffmann,
G. Hobom, and Y. Kawaoka.
1999.
Generation of influenza A viruses entirely from cloned cDNAs.
Proc. Natl. Acad. Sci. USA
96:9345-9350 |
| 32. |
Neumann, G.,
T. Watanabe, and Y. Kawaoka.
2000.
Plasmid-driven formation of influenza virus-like particles.
J. Virol.
74:547-551 |
| 33. | Pettersson, R., and L. Kääriäinen. 1973. The ribonucleic acids of Uukuniemi virus, a noncubical tick-borne arbovirus. Virology 56:608-619[CrossRef][Medline]. |
| 34. | Prehaud, C., N. Lopez, M. J. Blok, V. Obry, and M. Bouloy. 1997. Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment. Virology 227:189-197[CrossRef][Medline]. |
| 35. | Radecke, F., P. Spielhofer, H. Schneider, K. Kaelin, M. Huber, C. Dötsch, G. Christiansen, and M. A. Billeter. 1995. Rescue of measles virus from cloned DNA. EMBO J. 14:5773-5784[Medline]. |
| 36. | Roberts, A., and J. Rose. 1998. Recovery of negative-strand RNA viruses from plasmid DNAs: A positive approach to a negative field. Virology 247:1-6[CrossRef][Medline]. |
| 37. |
Rönnholm, R.
1992.
Localization to the Golgi complex of Uukuniemi virus glycoproteins G1 and G2 expressed from cloned cDNAs.
J. Virol.
66:4525-4531 |
| 38. | Rönnholm, R., and R. F. Pettersson. 1987. Complete nucleotide sequence of the M RNA segment of Uukuniemi virus encoding the membrane glycoproteins G1 and G2. Virology 160:191-202[CrossRef][Medline]. |
| 39. | Salvato, M. S., and E. M. Shimomaye. 1989. The complete sequence of lymphocytic choriomeningitis virus reveals a unique RNA structure and a gene for a zinc finger protein. Virology 173:1-10[CrossRef][Medline]. |
| 40. | Schmaljohn, C. S. 1996. Bunyaviridae: the viruses and their replication, p. 1447-1471. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology. Lippincott-Raven Publishers, Philadelphia, Pa. |
| 41. | Schnell, M. J., T. Mebatsion, and K.-K. Conzelmann. 1994. Infectious rabies viruses from cloned cDNA. EMBO J. 13:4195-4203[Medline]. |
| 42. |
Simons, J. F.,
U. Hellman, and R. F. Pettersson.
1990.
Uukuniemi virus S RNA: ambisense coding strategy, packaging of complementary strands into virions, and homology to members of the genus Phlebovirus.
J. Virol.
64:247-255 |
| 43. |
Simons, J. F., and R. F. Pettersson.
1991.
Host-derived 5' ends and overlapping complementary 3' ends of the two mRNAs transcribed from the ambisense S segment of Uukuniemi virus.
J. Virol.
65:4741-4748 |
| 44. |
Simons, J. F.,
R. Persson, and R. F. Pettersson.
1992.
Association of the nonstructural protein NSs of Uukuniemi virus with the 40S ribosomal subunit.
J. Virol.
66:4233-4241 |
| 45. | Sutter, G., M. Ohlmann, and V. Erfle. 1995. Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett. 371:9-12[CrossRef][Medline]. |
| 46. |
Ulmanen, I.,
P. Seppälä, and R. F. Pettersson.
1981.
In vitro translation of Uukuniemi virus-specific RNAs: identification of a nonstructural protein and a precursor to the membrane glycoproteins.
J. Virol.
37:72-79 |
| 47. |
Vialat, P.,
A. Billecocq,
A. Kohl, and M. Bouloy.
2000.
The S segment of Rift Valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice.
J. Virol.
74:1538-1543 |
| 48. |
Whelan, S. P. J.,
L. A. Ball,
J. N. Barr, and G. T. W. Wertz.
1995.
Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones.
Proc. Natl. Acad. Sci. USA
92:8388-8392 |
| 49. |
Zobel, A.,
G. Neumann, and G. Hobom.
1993.
RNA polymerase I catalysed transcription of insert viral cDNA.
Nucleic Acids Res.
21:3607-3614 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»